Cara Therapeutics Inc
Change company Symbol lookup
Select an option...
CARA Cara Therapeutics Inc
MATX Matson Inc
TECK Teck Resources Ltd
BCBNF Base Carbon Inc
PAVM PAVmed Inc
HTGC Hercules Capital Inc
NRG NRG Energy Inc
NLTX Neoleukin Therapeutics Inc
AROW Arrow Financial Corp
EQ Equillium Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). The Company is developing a class of product candidates KORSUVA (CR845/difelikefalin), which is a KOR agonist that targets the body’s peripheral nervous system, as well as certain immune cells. The Company is also conducting preclinical studies and clinical trials of CR845/difelikefalin-based product candidates. The Company also initiated a pharmacokinetic safety trial of multiple doses of Oral CR845 in hemodialysis patients to define bioequivalent tablet strengths to inform its ability to develop an oral tablet formulation for moderate-to-severe uremic pruritus. CR701 is a peripherally restricted, mixed-CB1/CB2 receptor agonist that selectively interacts with these cannabinoid receptor subtypes, with no off-target activities.

Closing Price
$9.39
Day's Change
0.27 (2.96%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.45
Day's Low
9.05
Volume
(Heavy Day)
Volume:
604,201

10-day average volume:
448,879
604,201
  • Prev Close
    9.12
  • Today's Open
    9.26
  • Day's Range
    9.05-9.45
  • Avg Vol (10-day)
    448.9K
  • Last (time)
    4:00p ET 06/24/22
  • Last (size)
    4
  • 52-Wk Range
    7.40 - 18.93
    LowHigh
  • (11/09/21 - 05/09/22)
    26.89%
  • 61.1%
  • Market Cap
    503.2M
  • Shares Outstanding
    53.6M
  • -1.79
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 59.18
  • (% of float 05/31/22)
    13.49

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.